by Richard W. Welch, PhD, Jim Campbell, Al Toledo, Dave Davis, Helen Latzgo, Gary Haupt, Kim Love, Jae M. Sly, Gary Cohen, Roselyn Eisenberg, J. Charles Whitbeck, Lydia Aldaz-Carroll, Huan Lou, David E. Lenz, Pinal C. Patel, and Douglas M. Cerasoli
Volume 5, Issue 2 (Summer 2006)
The developing biotechnology community may offer solutions and hope for recent world events that have focused attention on the vulnerability of the world’s population. Concerns about new pandemics have been raised by the emergence of new influenza strains and the re-emergence of older and even more highly virulent strains. In addition, there are fears that bioterrorism could involve agents such as anthrax or smallpox, and these threats become even more of a concern when you consider the increased mobility of such organisms via today’s commercial aviation. The ability of the biomedical community to respond rapidly to these shifting threats is more important than ever…
Citation:
Welch RW et al. Rapid Production of Recombinant Proteins Utilizing the PERLXpress Platform. BioProcess J, 2006; 5(2): 63-70. https://doi.org/10.12665/J52.Welch